SpineGuard Announces the Revision of Its 2022 Financial Calendar
02 Août 2022 - 6:00PM
Business Wire
Regulatory News:
SpineGuard (FR0011464452 – ALSGD) (Paris:ALSGD), an
innovative company that deploys its DSG® (Dynamic Surgical
Guidance) sensing technology to secure and streamline the placement
of bone implants, today announced a change in its financial
calendar for the second half of 2022.
Revised financial calendar for the second half of
2022
Event
Date*
2022 First-Half Results
September 15, 2022
(instead of September 14, 2022)
2022 Third-Quarter Sales
October 12, 2022
Note (*): Press releases are published after stock market
closes. This information is subject to modification.
About SpineGuard®
Founded in 2009 in France and the USA by Pierre Jérôme and
Stéphane Bette, SpineGuard is an innovative company deploying its
proprietary radiation-free real time sensing technology DSG®
(Dynamic Surgical Guidance) to secure and streamline the placement
of implants in the skeleton. SpineGuard designs, develops and
markets medical devices that have been used in over 90,000 surgical
procedures worldwide. Nineteen studies published in peer-reviewed
scientific journals have demonstrated the multiple benefits DSG®
offers to patients, surgeons, surgical staff and hospitals.
Building on these strong fundamentals and several strategic
partnerships, SpineGuard has expanded the scope of its DSG®
technology in innovative applications such as the « smart » pedicle
screw, the DSG Connect visualization and registration interface,
dental implantology and surgical robotics. DSG® was co-invented by
Maurice Bourlion, Ph.D., Ciaran Bolger, M.D., Ph.D., and Alain
Vanquaethem, Biomedical Engineer. SpineGuard has engaged in
multiple ESG initiatives.
For further information, visit www.spineguard.com
Disclaimer The SpineGuard securities may not be offered
or sold in the United States as they have not been and will not be
registered under the Securities Act or any United States state
securities laws, and SpineGuard does not intend to make a public
offer of its securities in the United States. This is an
announcement and not a prospectus, and the information contained
herein does and shall not constitute an offer to sell or the
solicitation of an offer to buy, nor shall there be any sale of the
securities referred to herein in the United States in which such
offer, solicitation or sale would be unlawful prior to registration
or exemption from registration.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20220802005736/en/
SpineGuard Pierre Jérôme CEO & Chairman Tel: +33 1 45
18 45 19 p.jerome@spineguard.com
SpineGuard Manuel Lanfossi CFO Tel: +33 1 45 18 45 19
m.lanfossi@spineguard.com
NewCap Investor Relations & Financial Communication
Mathilde Bohin Tel: +33 1 44 71 94 94 spineguard@newcap.eu
Spineguard (EU:ALSGD)
Graphique Historique de l'Action
De Mar 2024 à Avr 2024
Spineguard (EU:ALSGD)
Graphique Historique de l'Action
De Avr 2023 à Avr 2024